Technology

Eye Catching Stock: Natera, Inc. (NASDAQ: NTRA)

Natera, Inc. (NASDAQ: NTRA) stock traded volume of 597630 shares during its last trading session as compared to its average volume of 760422 shares over the recent month. NTRA ended its day with the above stream along the move of 0.74% and closed at the price of $32.76 before opening at $33.07. It has total market capitalization is $2297458682. 52 week range of the stock remained $ 11.08 – 33.55 while its day lowest price was $32.25 and its hit its day highest price at $33.07

Natera, Inc. (NASDAQ: NTRA) and CBR (Cord Blood Registry) announced the acquisition by CBR, a California Cryobank Life Sciences company, and the world’s largest newborn stem cell collection and storage organization, of Natera’s Evercord™ cord blood and tissue banking business.

“This divestiture will allow Natera to focus squarely on its core genetic testing business in reproductive health, oncology and organ transplantation,” said Steve Chapman, Natera’s CEO. “We are proud of what we’ve accomplished with Evercord and believe that CBR, as the recognized industry leader in newborn stem cells, is the best partner for cord blood services moving forward.”

“As a pillar of the California Cryobank Life Sciences (CCLS) organization, CBR is built on scientific excellence, leadership, and best-in-class services,” said Richard Jennings, California Cryobank Life Sciences, Chief Executive Officer. “Natera shares our core values and commitment to quality. We look forward to safeguarding these newborn stem cells and allowing the Evercord families to take advantage of future advances in cellular therapies and regenerative medicine.”

CBR will work closely with Natera to ensure a smooth transition for customers and ordering clinics.

Convergence Healthcare Advisors LLC served as exclusive strategic advisor to Natera, Inc. on the sale of the Evercord business.

Leave a Reply

Your email address will not be published. Required fields are marked *